421 related articles for article (PubMed ID: 9221993)
1. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
Cheung AP; Lu JK; Chang RJ
Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Pastor CL; Griffin-Korf ML; Aloi JA; Evans WS; Marshall JC
J Clin Endocrinol Metab; 1998 Feb; 83(2):582-90. PubMed ID: 9467578
[TBL] [Abstract][Full Text] [Related]
3. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome.
White D; Leigh A; Wilson C; Donaldson A; Franks S
Clin Endocrinol (Oxf); 1995 May; 42(5):475-81. PubMed ID: 7621565
[TBL] [Abstract][Full Text] [Related]
6. Pituitary responsiveness to gonadotrophin-releasing hormone agonist stimulation: a dose-response comparison of luteinizing hormone/follicle-stimulating hormone secretion in women with polycystic ovary syndrome and normal women.
Cheung AP; Chang RJ
Hum Reprod; 1995 May; 10(5):1054-9. PubMed ID: 7657740
[TBL] [Abstract][Full Text] [Related]
7. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
8. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
10. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
[TBL] [Abstract][Full Text] [Related]
11. LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome.
Hohmann FP; Laven JS; Mulders AG; Oberyé JJ; Mannaerts BM; de Jong FH; Fauser BC
J Endocrinol Invest; 2005 Dec; 28(11):990-7. PubMed ID: 16483177
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
Steingold K; De Ziegler D; Cedars M; Meldrum DR; Lu JK; Judd HL; Chang RJ
J Clin Endocrinol Metab; 1987 Oct; 65(4):773-8. PubMed ID: 3116031
[TBL] [Abstract][Full Text] [Related]
13. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
Kettel LM; Roseff SJ; Berga SL; Mortola JF; Yen SS
Fertil Steril; 1993 Mar; 59(3):532-8. PubMed ID: 8458453
[TBL] [Abstract][Full Text] [Related]
14. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
15. The role of changing pulse frequency in the regulation of ovulation.
Marshall JC; Griffin ML
Hum Reprod; 1993 Nov; 8 Suppl 2():57-61. PubMed ID: 8276970
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
Barontini M; García-Rudaz MC; Veldhuis JD
Arch Med Res; 2001; 32(6):544-52. PubMed ID: 11750729
[TBL] [Abstract][Full Text] [Related]
17. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
McCartney CR; Eagleson CA; Marshall JC
Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
[TBL] [Abstract][Full Text] [Related]
18. Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome.
Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J
Hum Reprod; 1993 Nov; 8 Suppl 2():197-9. PubMed ID: 8276960
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine control in polycystic ovary-like syndrome.
Schoemaker J
Gynecol Endocrinol; 1991 Dec; 5(4):277-88. PubMed ID: 1796749
[TBL] [Abstract][Full Text] [Related]
20. Effects of gonadotropin-releasing hormone pulse-frequency modulation on luteinizing hormone, follicle-stimulating hormone and testosterone secretion in hypothalamo/pituitary-disconnected rams.
Wu FC; Irby DC; Clarke IJ; Cummins JT; de Kretser DM
Biol Reprod; 1987 Oct; 37(3):501-10. PubMed ID: 3118979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]